News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News Proofpoint Introduces Active Exploits Protection to Help Organizations Prioritize Vulnerability Patching for Real-World Attacks in the AI Era News Holafly partners with Valientes Colombia to support community-led initiatives and address the social impact of tourism News Interact Enters a New Era of Growth with Brand Evolution, AI Innovation, and Industry Recognition News Leading Philippine Telecom Provider Selects Synchronoss to Deliver Personal Cloud Solutions to 54 Million Customers News Senteon Expands MSP Automation Capabilities Through Integration Partnership with Rewst News AvidXchange Powers Embedded AP Payments for Acumatica Customers